National and Kapodistrian University of Athens
Μελέτη του μεταγραφικού παράγοντα E2F-1 σε αδενοκαρκινώματα γαστροοισοφαγικής συμβολής και σε αδενοκαρκινώματα οισοφάγου Barrett's. Η σχέση του E2F-1 με τις κινητικές παραμέτρους της κυτταρικής αύξησης και της απόπτωσης: συσχέτιση με τις κλινικοπαθολογικές παραμέτρους
Abstract
dc:descriptionE2f-1 is a significant transcriptional factor, that receives signals from phase G1/S regulators and expresses various cellular functions, such as DNA formation and repair, mitosis and apoptosis. Its role in cellular proliferation and apoptosis has been studied in many experimental models and a few of these studies concerning human malignancies have been published, so far. The aim of this study is to investigate the role of E2F-1 in tumor growth, apoptosis and other clinical and pathological parameters of Barrett’s adenocarcinomas as well as in adenocarcinomas of the gastroesophageal junction. The relationship of E2F-1 and p53’s expression has also been studied. Method: The expression levels of E2F-1, p53, Ki-67 and caspase-3 were studied by immuno-istochemistry in 55 (fifty-five) cases of esophageal adenocarcinoma (18 cases of Barrett’s adenocarcinoma and 37 adenocarcinomas of the gastroesophageal junction). In order to ensure greater accuracy in the evaluation of apoptosis, TUNEL technique was performed in 20 of the samples. The outcomes were evaluated in unison as well as in relation to the clinical and pathological findings of the patients. Results: The mean percentage of E2F-1’s expression was 39.43% (±31.19%) in Barrett’s adenocarcinomas and 42% (±30.47%) in adenocarcinomas of the gastroesophageal junction. The expression rate of proliferation indicator Ki-67 was found to be 38.15% (±18.71) in Barrett’s adenocarcinomas and 38.93% (±16.32) in adenocarcinomas of the gastroesophageal junction. High expression of E2F-1 was associated with a low expression of Ki-67 (p=0.038) in all of the samples. Positive staining for p53 was observed in 50% of all Barrett’s adenocarcinomas and in 67.6% in adenocarcinomas of the gastroesophageal junction. Whenever E2F-1 was greatly expressed, so was p53, on both types of cancer. Caspase-3 was expressed in 1.025% (±0.3948) of all Barrett’s adenocarcinomas and in 0.9783% (±0.4635) of all gastroesophageal junction adenocarcinomas. The inversed relation between E2F-1 and Ki-67 was statistically significant (p=0.038) both in Barrett’s and gastroesophageal adenocarcinomas. The E2F-1 expression rates were also directly associated with the p53 expression rates. Moreover, E2F-1 high levels were inversely related with survival (p=0.08) in gastroesophageal junction adenocarcinomas. Finally, the lymph node infiltration was seriously associated with grim survival (p=0.07). Conclusions: E2F-1 expression is inversely related with cellular proliferation (Ki-67), it is directly related with p53 positive expression, it is not connected with caspase-3 expression (apoptosis), and tends to be related with lymph node infiltration and grim survival. E2F-1 seems to act as a tumor suppressor both in Barrett’s and gastroesophageal adenocarcinomas.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2005
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Mariolis-Sapsakos, Theodoros
- Μαριόλης-Σαψάκος, Θεόδωρος
Subjects
dc:subject × 17- Μεταγραφικός παράγοντας E2F-1
- Αδενοκαρκίνωμα Barrett
- Αδενοκαρκίνωμα γαστροοισοφαγικής συμβολής
- p53, Ογκοκατασταλτική κυτταρική πρωτεϊνη
- Αντιγόνο Ki-67
- Κασπάση-3
- Ανάστροφη σχέση E2F-1 και κυτταρικού πολλαπλασιασμού
- Transcriptional factor E2F-1
- Adenocarcinomas gastroesophageal juction
- Reverse relation of E2F-1 with cellular proliferation
- p53 tumour - sypressor protein
- Antigen Ki - 67
- Caspase-3
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/22563